HTL-0030310

N/A

Report date: 2025/03/05 20:00:52
NME

Base Information

Drug NameHTL-0030310
Drug Alias NameHTL-0030310
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 5 agonists
TargetsSomatostatin receptor 5
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNxera Pharma UK Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A